SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
JNCYin
Lv1
70 积分
2023-08-01 加入
最近求助
最近应助
互助留言
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
1个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
1个月前
已完结
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
1个月前
已完结
Abstract 1039: Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of non-small cell lung cancer (NSCLC) - the MEDAL study
2个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
3个月前
已完结
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
3个月前
已完结
Genome Sequencing for Diagnosing Rare Diseases
3个月前
已完结
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
11个月前
已完结
Re: Chia et al.: Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9)
1年前
已完结
Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops
1年前
已完结
没有进行任何应助
disclosure是免费下载的。需要的是supplementary figures和tables
1个月前
名称是摘要,但实际上确实是全文
2个月前
仅为摘要,不是全文
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论